Compared with their study, we screened the 9 more m6A regulators and explored the CNV in the public database, evaluated the copy number variation (CNV) data of m6A on the OS and DFS of patients with PAAD, and further verified the prognostic value of ALKBH5 in pancreatic cancer. Here, ALKBH5 is linked to pancreatic adenocarcinoma.